Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelodysplastic Syndrome MDS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT01890486
What this trial is testing

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+7 more
Wake Forest University Health Sciences 2,000
Early research (Phase 1)Looking for participantsNCT07462780
What this trial is testing

A Phase I Clinical Trial to Evaluate CMS-D017 Following Single and Multiple Doses in Healthy Participants

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria, PNHComplement-mediated Kidney Disease
Shenzhen Kangzhe Biotechnology Co., Ltd. 88
Early research (Phase 1)Study completedNCT04017546
What this trial is testing

CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory AML or MDS

Who this might be right for
AMLMDS
Cyclacel Pharmaceuticals, Inc. 14
Not applicableUnknownNCT00899327
What this trial is testing

Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Oxford University Hospitals NHS Trust 200
Testing effectiveness (Phase 2)WithdrawnNCT00867061
What this trial is testing

Efficacy and Safety of 5-day Dosing of ON 01910.Na in Intermediate-1,-2, or High Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic Syndrome
Traws Pharma, Inc.
Testing effectiveness (Phase 2)UnknownNCT01133886
What this trial is testing

Use of Decitabine in Myelodysplastic Syndrome (MDS) Following Azacitidine (AZA) Failure

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome
King's College London 50
Testing effectiveness (Phase 2)UnknownNCT05066958
What this trial is testing

Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT

Who this might be right for
Acute Myeloid LeukemiaHigh Risk Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia, in Relapse+4 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 20
Testing effectiveness (Phase 2)Study completedNCT00413114
What this trial is testing

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndromes
Gemin X 24
Not applicableStudy completedNCT04036448
What this trial is testing

A Non-interventional Study of REVLIMID® (Lenalidomide) Treatment of IPSS Low- or Intermediate-1-risk Myelodysplastic Syndromes Associated With a Deletion 5q or Refractory/Relapsed Mantle Cell Lymphoma in Korea

Who this might be right for
Myelodysplastic SyndromesLymphoma, Mantle-CellLymphoma, Follicular
Celgene 28
Not applicableStudy completedNCT01933035
What this trial is testing

Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.

Who this might be right for
Immune ThrombocytopeniaChemotherapy Induced ThrombocytopeniaMyelodysplasia+1 more
Beth Israel Medical Center 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06298955
What this trial is testing

Long-Term Safety, Tolerability and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
Omeros Corporation 25
Not applicableAvailableNCT05593185
What this trial is testing

Expanded Access Program (EAP) for Galinpepimut-S (GPS) in Patients Diagnosed With AML or MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Sellas Life Sciences Group
Large-scale testing (Phase 3)Ended earlyNCT00967343
What this trial is testing

Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor

Who this might be right for
Myeloid LeukemiaLymphoblastic LeukemiaLymphoma+3 more
Kiadis Pharma 40
Early research (Phase 1)Study completedNCT00070538
What this trial is testing

VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Vion Pharmaceuticals
Early research (Phase 1)Study completedNCT03932643
What this trial is testing

ONC-201 Maintenance Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome After Stem Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
University of Nebraska 20
Testing effectiveness (Phase 2)Ended earlyNCT00720850
What this trial is testing

Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Who this might be right for
Myelodysplastic SyndromesAcute Myelogenous Leukemia
Technische Universität Dresden 10
Not applicableUnknownNCT01331603
What this trial is testing

Assessment of Labile Plasma Iron (LPI) in Myelodysplastic Syndromes (MDS) and Primary Myelofibrosis

Who this might be right for
Myelodysplastic SyndromePrimary Myelofibrosis
Wolfson Medical Center 50
Testing effectiveness (Phase 2)Study completedNCT02428686
What this trial is testing

Treatment of Anemia With Epoetin Beta in Low Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic Syndromes
Groupe Francophone des Myelodysplasies 50
Large-scale testing (Phase 3)Ended earlyNCT05709093
What this trial is testing

Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine (AZA) Versus AZA Monotherapy in Treatment-naïve Patients With Higher-risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic Syndromes(MDS)
TJ Biopharma Co., Ltd. 10
Early research (Phase 1)Study completedNCT01020539
What this trial is testing

Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic SyndromeJuvenile Myelomonocytic Leukemia
Columbia University 18
Next Page